SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-073967
Filing Date
2022-11-21
Accepted
2022-11-18 21:13:40
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_viveon.htm   iXBRL 10-Q 693802
2 CERTIFICATION f10q0922ex31-1_viveon.htm EX-31.1 7841
3 CERTIFICATION f10q0922ex31-2_viveon.htm EX-31.2 8595
4 CERTIFICATION f10q0922ex32-1_viveon.htm EX-32.1 3316
5 CERTIFICATION f10q0922ex32-2_viveon.htm EX-32.2 3331
  Complete submission text file 0001213900-22-073967.txt   4461722

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vhaq-20220930.xsd EX-101.SCH 54932
7 XBRL CALCULATION FILE vhaq-20220930_cal.xml EX-101.CAL 26382
8 XBRL DEFINITION FILE vhaq-20220930_def.xml EX-101.DEF 217763
9 XBRL LABEL FILE vhaq-20220930_lab.xml EX-101.LAB 424956
10 XBRL PRESENTATION FILE vhaq-20220930_pre.xml EX-101.PRE 228368
52 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_viveon_htm.xml XML 579492
Mailing Address C/O GIBSON, DEAL, AND FLETCHER, P. C. 3953 NORCROSS GA 30092
Business Address C/O GIBSON, DEAL, AND FLETCHER, P. C. 3953 NORCROSS GA 30092 4045797978
Viveon Health Acquisition Corp. (Filer) CIK: 0001823857 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39827 | Film No.: 221403338
SIC: 2834 Pharmaceutical Preparations